GN
Genelux Corporation (GNLX)
NASDAQ·Healthcare·Biotechnology
$2.89
-4.79%
Mkt Cap $106.46M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$17.33
Range $16.00 – $20.00
Implied Upside
+500.7%
Consensus $17.33 vs current $2.89
NASDAQ·Healthcare·Biotechnology
$2.89
-4.79%
Mkt Cap $106.46M
No recent rating data.
Price Target (3 analysts)
$17.33
Range $16.00 – $20.00
+500.7%
Consensus $17.33 vs current $2.89